Kutlwano R. Xulu - Publications

Navigating the Intricacies of Tumor Heterogeneity: An Insight into Potential Prognostic Breast Cancer Biomarkers.

Journal: Biomarker insights

Published: August 23, 2023

Secretomics reveals hormone-therapy of breast cancer may induce survival by facilitating hypercoagulation and immunomodulation in vitro.

Journal: Scientific reports

Published: July 07, 2023

Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches.

Journal: Frontiers in genetics

Published: November 02, 2022

Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 31, 2022

Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: August 18, 2022

Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation.

Journal: International journal of molecular sciences

Published: February 28, 2021

Combined Anastrozole and Antiplatelet Therapy Treatment Differentially Promotes Breast Cancer Cell Survival.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

Published: April 04, 2020

HAART induces cell death in a cervical cancer cell line, HCS-2: A Scanning Electron Microscopy study.

Journal: Journal of microscopy and ultrastructure

Published: November 18, 2015